Haircare, Salon Trends and Hair-Loss Science — 2026-10-01
Singapore's CellResearch reports breakthrough clinical data on cord lining stem cell actives showing 43% improvement in hair breakage resistance and 14% reduction in scalp redness. Meanwhile, Japan's MTG launches its first haircare line under the SIXPAD brand, and Korea's scalp care market surges 65% at duty-free retailers as premium multi-step regimens drive global expansion through 2035.
Haircare, Salon Trends and Hair-Loss Science — 2026-10-01
Top developments
CellResearch Cord Lining Stem Cell Active Shows Clinical Efficacy in Hair Strength and Scalp Health
Singapore-based CellResearch Corporation presented independent laboratory data on September 30 (one day ago) demonstrating that PTT-6®, a cord lining stem cell active, delivered 43% improvement in hair breakage resistance and 14% reduction in scalp redness across two standardized studies. The announcement came at AMWC Japan, a major dermatology and aesthetic medicine conference. The data arrives as the global hair and scalp care category expands from USD 93.6 billion to USD 150.5 billion, signaling accelerating clinical validation of regenerative ingredients in mainstream haircare.
MTG Launches First SIXPAD Haircare Line; Positions Hair as "Training" Target
Japanese health-tech brand MTG unveiled its inaugural haircare series under the SIXPAD label on September 29, launching three items designed to "train" hair fiber and scalp condition. The line will debut on Rakuten on October 13 before broader rollout on MTG's direct store and Amazon from November 18. The launch reflects industry-wide premiumization and functional positioning of haircare as a disciplined regimen comparable to fitness or skincare routines.
South Korea Duty-Free Scalp Care Sales Surge 65%; Scalp-as-Skincare Trend Accelerates
New Shinsegae Duty Free data released September 28 shows high-function scalp and hair care product sales jumped 65% year-over-year, signaling mainstream adoption of "scalp care" as a dedicated beauty category equivalent to facial skincare. Strong UV exposure and outdoor activity in the region have driven consumers to treat scalp health with the same rigor as complexion management. Category leaders include specialized serums, tonics, and multi-step protocols.
Premium Hair Growth Serum Sets Market Forecast to Expand Through 2035 on Scalp Health Demand
IndexBox released a market forecast (September 30) projecting global hair growth serum set expansion through 2035, driven by rising consumer demand for preventive scalp health and premium multi-step regimens. The category shift reflects industry-wide move toward layered, ingredient-focused protocols rather than single-product solutions—aligning with bond-repair and K18-style sequential treatment models gaining traction in professional salons.
Meditoxin Expands Botulinum Toxin Use to Hair Loss and Follicle Regeneration
South Korea's Meditoxin announced on September 29 that its botulinum toxin formulation (Coretox) is being positioned for hair loss treatment and follicle regeneration—moving beyond cosmetic applications into therapeutic dermatology. The company shared updated clinical insights with 1,400+ domestic physicians, signaling regulatory and market confidence in neurotoxin-based hair regeneration protocols.
Local view
Japan (Fashion Snap): SIXPAD's entry into haircare reflects MTG's broader shift into preventive wellness; the brand positions hair training as equivalent to muscle conditioning, appealing to fitness-conscious consumers. The October 13 pre-launch on Rakuten signals confidence in e-commerce and direct-to-consumer channels for premium haircare debuts.
South Korea (Sports Chosun, Issue Today): Scalp care now ranks alongside facial skincare in retail priority; the 65% sales surge at Shinsegae Duty Free reflects both consumer demand and retailer commitment to category expansion. Local beauty media frames scalp care as a "new beauty standard" equivalent to anti-aging skincare.
South Korea (Financial News): Cosmax, the region's largest cosmetics ODM manufacturer, announced on September 30 that it is leveraging AI and biodata from 22 million Korean and Japanese health checkup records to develop personalized haircare technology, positioning predictive hair loss assessment as a competitive edge in the premium segment.
Context & numbers
- Global hair and scalp care market: USD 93.6 billion (current) → USD 150.5 billion (forecast), representing 61% expansion
- South Korea duty-free scalp/hair care sales growth: +65% YoY as of late September 2026
- CellResearch PTT-6 clinical metrics: 43% hair breakage resistance improvement; 14% scalp redness reduction (two independent lab studies)
- SIXPAD haircare debut: October 13, 2026 (Rakuten pre-launch); November 18, 2026 (MTG Direct and Amazon rollout)
On the radar
- Extended-release oral minoxidil Phase 3 data expected H2 2026 – Topline results from Study 304 (second Phase 3 male trial) anticipated in coming weeks; female AGA trial (Study 306) currently enrolling
- Dyson Airsmooth hot brush and new hair straightener – Professional and consumer-grade launches continue; Independent review published September 30 compares performance across hair types
- Japanese innovation calendar: Melmood Hydro-Change Treatment (Oージオ) launched October 1, 2026; IIKAMI hair tea (Seraphic Corp.) entered general sale as of September 30 (3 hours prior to publication)
- Cosmax AI haircare platform: 22-million-record biodata integration suggests imminent launch of predictive hair-loss assessment tools for premium ODM clients (watch for Q4 2026 announcements)
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
